A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 months

Title
A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11–12 months
Authors
Keywords
DTaP, Polio, Hib, Hepatitis B, Hexavalent, Vaccine, Safety, Immunogenicity
Journal
VACCINE
Volume 34, Issue 33, Pages 3810-3816
Publisher
Elsevier BV
Online
2016-06-27
DOI
10.1016/j.vaccine.2016.05.054

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started